Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$6.68 - $11.07 $69,472 - $115,128
-10,400 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$6.26 - $11.03 $23,788 - $41,914
-3,800 Reduced 26.76%
10,400 $69,000
Q3 2020

Nov 12, 2020

BUY
$4.71 - $7.36 $66,882 - $104,512
14,200 New
14,200 $81,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $1.19B
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.